Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Publication year range
1.
Nihon Rinsho ; 59 Suppl 8: 709-17, 2001 Dec.
Article in Japanese | MEDLINE | ID: mdl-11808297
2.
Gan To Kagaku Ryoho ; 25(7): 1079-81, 1998 Jun.
Article in Japanese | MEDLINE | ID: mdl-9644324

ABSTRACT

The patient was a 71-year-old man who had been diagnosed as having a left renal pelvic cancer with liver metastasis. We performed total left nephroureterectomy with lymphnode cleaning and partial resection of the liver. Because abdominal CT 5 months after the operation revealed multiple metastasis of the liver, we performed chemotherapy with a regimen consisting of methotrexate 50 mg (intravenous injection), cisplatin 30 mg and pirarubicin 20 mg (intraarterial infusion), and leucovorin 3 mg (intramuscular injection), three times at intervals of 6 hours. Ten days after chemotherapy, CT revealed the disappearance of most of the liver metastatic lesions, and a partial response was obtained. We are now performing the regimen at an interval of a month to a month and one-half to control the metastatic lesions.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Carcinoma, Transitional Cell/drug therapy , Carcinoma, Transitional Cell/secondary , Kidney Neoplasms/drug therapy , Liver Neoplasms/drug therapy , Liver Neoplasms/secondary , Aged , Cisplatin/administration & dosage , Doxorubicin/administration & dosage , Doxorubicin/analogs & derivatives , Hepatic Artery , Humans , Infusions, Intra-Arterial , Infusions, Intravenous , Injections, Intramuscular , Kidney Neoplasms/pathology , Kidney Neoplasms/surgery , Kidney Pelvis , Leucovorin/administration & dosage , Lymph Node Excision , Lymphatic Metastasis , Male , Methotrexate/administration & dosage
3.
J Surg Oncol ; 64(1): 36-41, 1997 Jan.
Article in English | MEDLINE | ID: mdl-9040799

ABSTRACT

BACKGROUND: We studied the usefulness of nuclear DNA patterns and argyrophylic nucleolar organizer regions (AgNORs) for evaluating the malignant potential of colorectal cancers, which is increasingly being regarded as important in predicting patients' prognosis and for their appropriate postoperative management. METHODS: We measured these two factors in curatively resected specimens of 91 colorectal cancer cases, which were followed up for 1,549 +/- 788 days postoperatively. Ploidy pattern was either diploid or aneuploid, and AgNORs score was either low (LS) or high (HS). Thus, we classified our cases into Group I (diploid, LS). Group II (aneuploid, LS), Group III (diploid, HS), and Group IV (aneuploid, HS). Postoperative survival curves in the cases belonging to these groups were analyzed. RESULTS: Survival rates in Groups I and II were significantly higher than those in Group IV. Correlation between subgroups and clinicopathological factors such as average age, histologic type, depth of invasion, and histologic stage were observed. Incidence of lymph node metastasis at the time of operation and that of postoperative recurrence were higher in group IV than that in groups I and II. CONCLUSIONS: Measurement of DNA ploidy patterns and AgNORs score were found to be useful in evaluating malignant potential of colorectal cancers.


Subject(s)
Colorectal Neoplasms/pathology , DNA, Neoplasm/analysis , Nucleolus Organizer Region/pathology , Adult , Aged , Aged, 80 and over , Colorectal Neoplasms/chemistry , Colorectal Neoplasms/mortality , Colorectal Neoplasms/surgery , DNA, Neoplasm/genetics , Female , Humans , Lymphatic Metastasis , Male , Middle Aged , Ploidies , Prognosis , Silver Staining , Survival Rate
4.
Gan To Kagaku Ryoho ; 14(3 Pt 1): 728-31, 1987 Mar.
Article in Japanese | MEDLINE | ID: mdl-3103542

ABSTRACT

A 55-year-old woman with gastric cancer underwent laparotomy and was found to have an unresectable tumor at the MC region, characterized by S3 (invasion into the pancreas), N3, P0, H0, Borrmann-II and moderately differentiated tubular adenocarcinoma. She was then treated by combined administration of cis-dichlorodiammine platinum (CDDP), mitomycin C and 5-fluorouracil (5-FU). A complete response was confirmed by upper gastrointestinal roentgenography and endoscopy. Upon reoperation 4 months after the initial laparotomy, a successful total radical gastrectomy with R2 (partially R3) lymph node dissection was performed. Histological examination of the specimens, including the stomach and lymph nodes, revealed no cancer cells in any region.


Subject(s)
Adenocarcinoma/drug therapy , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Stomach Neoplasms/drug therapy , Adenocarcinoma/pathology , Adenocarcinoma/surgery , Cisplatin/administration & dosage , Female , Fluorouracil/administration & dosage , Gastrectomy , Humans , Lymph Node Excision , Middle Aged , Mitomycin , Mitomycins/administration & dosage , Prognosis , Stomach Neoplasms/pathology , Stomach Neoplasms/surgery
SELECTION OF CITATIONS
SEARCH DETAIL
...